Sun Pharmaceutical Shows Mixed Trends Amid Strong Long-Term Growth Performance
Sun Pharmaceutical Industries is trading at Rs 1741.05, reflecting mixed trends in its moving averages. With a market cap of Rs 4,17,208.36 crore, the company has a P/E ratio of 35.25. It has outperformed the Sensex over one year but shows a year-to-date decline. Long-term growth remains strong.
Sun Pharmaceutical Industries has shown notable activity today, trading at Rs 1741.05, consistent with its sector performance. The stock's current price is above its 5-day and 50-day moving averages, yet below the 20-day, 100-day, and 200-day moving averages, indicating mixed short to long-term trends.With a market capitalization of Rs 4,17,208.36 crore, Sun Pharma operates within the Pharmaceuticals & Biotechnology industry, boasting a price-to-earnings (P/E) ratio of 35.25, slightly above the industry average of 35.04.
In terms of performance metrics, Sun Pharmaceutical Industries has delivered a 1-year return of 13.59%, outperforming the Sensex, which recorded an 11.19% gain. Over the past week, the stock has increased by 3.12%, while it has seen a slight decline of 0.75% over the past month. Year-to-date, the stock is down by 7.73%, contrasting with the Sensex's positive performance of 5.31%.
Over the longer term, Sun Pharma has demonstrated significant growth, with a 3-year performance of 96.61% and a remarkable 5-year increase of 293.67%, both surpassing the Sensex's respective gains.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
